Prior research showed that decreased ovarian reserve, represented by low oocyte yield during in-vitro fertilization (IVF) treatment or low Anti-Müllerian hormone (AMH), could be associated with an increased risk of developing preeclampsia (PE) during pregnancy [1]. This evidence concerns the gene AMH and preeclampsia.